Pirfenidone Capsule, 267 Mg Capsule
Product Images NDC 33342-461

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Pirfenidone Capsule, 267 Mg (NDC 33342-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Pirfenidone 267 mg Outer Carton 63s Capsules)

This is a 14-Day Titration Pack of Pirfenidone capsules, each containing 267mg of Pirfenidone. The pack includes 63 capsules to be used over two weeks. It is manufactured by Macleods Pharma USA, Inc. The dosing instructions involve taking one capsule three times a day in week 1 and two capsules three times a day in week 2. The usual dosage information can be found in the package insert. Store the capsules between 20°C to 25°C and keep them out of reach of children.*

FDA Label Image

Pirfenidone-fig-01 (Pirfenidone 267mg Fig 01)

This text provides information about the percentage of patients experiencing worsening, no decline, decrease, or increase in %FVC (Forced Vital Capacity) from baseline to Week 52. It compares the outcomes between Pirfenidone and Placebo in a study with a sample size of 278 and 277 respectively. The document also includes numerical values for the changes observed in the study.*

FDA Label Image

1 (Pirfenidone 267mg Inner Carton 21s 01)

This text is a label for Pirfenidone capsules, USP 267 mg, manufactured by Macleods Pharma USA. The label provides information on the dosage, packaging, manufacturer details, and storage instructions for the medication. It includes details such as the number of capsules in a unit dose, the NDC number, and the manufacturer's address in Princeton, NJ, and India. Dosage and administration information can be found in the package insert, and storage instructions recommend storing between 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F).*

FDA Label Image

1 (Pirfenidone 267mg Inner Carton 42 Capsules)

This is a label of inner carton for Pirfenidone Capsules, USP 267 mg. Each carton contains 42 capsules in a 7 x 6 unit-dose configuration. The capsules are intended for Week 2 dosing of Pirfenidone. The product is manufactured by Macleods Pharma USA, Inc. for Macleods Pharmaceuticals Ltd. The recommended storage temperature is between 20° to 25°C (68° to 77°F). The label provides the National Drug Code (NDC) for the product along with dosage information. It is important to consult the package insert for detailed dosage and administration instructions.*

FDA Label Image

1 (Pirfenidone 267mg Inner Carton Mainta Packs)

This is a description of a maintenance pack of Pirfenidone Capsules, USP 267 mg. The pack contains 63 capsules, organized in 7 sets of 9 unit doses. The capsules are manufactured for Macleods Pharma USA, Inc., with manufacturing details provided for Macleods Pharmaceuticals Ltd. The pack is designed for weekly use, with each capsule containing Pirfenidone, USP 267 mg. Storage instructions and dosage information are also included.*

FDA Label Image

1 (Pirfenidone 267mg Outer Carton Mainta Pack)

This is a description for Pirfenidone capsules, USP 267 mg, in an outer carton. The outer carton contains 4 Weekly Packs with a total of 252 capsules. Each weekly pack has 63 capsules. The manufacturer is Macleods and it is manufactured for Macleods Pharma USA, Inc. The usual dosage can be found in the package insert. It is advised to store the capsules at 20° to 25°C (68° to 77°F) with permitted excursions between 15° to 30°C (59° to 86°F).*

FDA Label Image

111 (Pirfenidone Capsules 267mg)

Description: This product is a capsule containing Pirfenidone, USP 267 mg. The NDC number is 33342-461-58. The usual dosage instructions can be found in the package insert. The capsules should be stored at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). It is important to keep this medication out of reach of children. The manufacturing information indicates it is manufactured in Himachal Pradesh, India.*

FDA Label Image

Pirfenidone-fig-02 (Pirfenidone Fig 02)

FDA Label Image

Pirfenidone-fig-03 (Pirfenidone Fig 03)

FDA Label Image

Pirfenidone-str (Pirfenidone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.